flâneur

How antiviral pill molnupiravir shot ahead in the COVID drug hunt

nature.com · 628 words · saved by 1 readers

The Merck pill, which could become the first oral antiviral COVID treatment, forces the SARS-CoV-2 coronavirus to mutate itself to death.

Email Bluesky Facebook LinkedIn Reddit Whatsapp X Access to this article via ICE Institution of Civil Engineers is not available. Change institution Buy or subscribe The pharmaceutical firm Merck announced last week that an antiviral pill it’s developing can cut hospitalizations and deaths among people with COVID-19 by half. The results haven’t yet been peer reviewed. But if the drug candidate, molnupiravir, is authorized by regulators, it would be the first oral antiviral treatment for COVID-19. By contrast, the other currently authorized drugs must be delivered intravenously or injected. Acc

saved by

related reading